Costanzo Maria Rosa, Saltzberg Mitchell, O'Sullivan Jeanne, Sobotka Paul
Midwest Heart Foundation, Lombard, Illinois, USA.
J Am Coll Cardiol. 2005 Dec 6;46(11):2047-51. doi: 10.1016/j.jacc.2005.05.099. Epub 2005 Nov 9.
We sought to determine if ultrafiltration before intravenous (IV) diuretics in patients with decompensated heart failure and diuretic resistance results in euvolemia and early discharge without hypotension or worsening renal function.
Heart failure patients with renal insufficiency and diuretic resistance have increased hospital mortality and length of stay. Peripheral veno-venous ultrafiltration may re-establish euvolemia and diuretic responsiveness.
Ultrafiltration was initiated within 4.7 +/- 3.5 h of hospitalization and before IV diuretics in 20 heart failure patients with volume overload and diuretic resistance (age 74.5 +/- 8.2 years; 75% ischemic disease; ejection fraction 31 +/- 15%) and continued until euvolemia. Re-evaluation was each hospital day, at 30 days, and at 90 days.
A total of 8,654 +/- 4,205 ml were removed with ultrafiltration. Twelve patients (60%) were discharged in < or =3 days. One patient was readmitted in 30 days. Weight (p = 0.006), Minnesota Living with Heart Failure scores (p = 0.003), and Global Assessment (p = 0.00003) improved after ultrafiltration and at 30 and 90 days. Median B-type natriuretic peptide levels decreased after ultrafiltration (from 1,230 pg/ml to 788 pg/ml) and at 30 days (815 pg/ml) (p = 0.035). Blood pressure, renal function, and medications were unchanged.
In heart failure patients with volume overload and diuretic resistance, ultrafiltration before IV diuretics effectively and safely decreases length of stay and readmissions. Clinical benefits persist at three months.
我们试图确定,对于失代偿性心力衰竭且存在利尿剂抵抗的患者,在静脉注射利尿剂之前进行超滤是否能实现血容量正常并早期出院,同时不会出现低血压或肾功能恶化。
伴有肾功能不全和利尿剂抵抗的心力衰竭患者,其医院死亡率和住院时间均增加。外周静脉 - 静脉超滤可能会重建血容量正常状态和利尿剂反应性。
对20例存在容量超负荷和利尿剂抵抗的心力衰竭患者(年龄74.5±8.2岁;75%为缺血性疾病;射血分数31±15%)在住院4.7±3.5小时内且在静脉注射利尿剂之前开始进行超滤,并持续至血容量正常。每天、30天和90天时进行重新评估。
通过超滤共清除8654±4205毫升。12例患者(60%)在≤3天内出院。1例患者在30天内再次入院。超滤后以及在30天和90天时,体重(p = 0.006)、明尼苏达心力衰竭生活评分(p = 0.003)和整体评估(p = 0.00003)均有所改善。超滤后(从1230皮克/毫升降至788皮克/毫升)以及30天时(815皮克/毫升),B型利钠肽水平中位数下降(p = 0.035)。血压及肾功能及用药情况未发生变化。
对于存在容量超负荷和利尿剂抵抗的心力衰竭患者,在静脉注射利尿剂之前进行超滤可有效且安全地缩短住院时间和再入院率。临床益处持续三个月。